Phase II trial of MEDI0457 and durvalumab for patients with recurrent/metastatic HPV-associated cancers. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results